Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum
about
RhoA-mediated Ca2+ sensitization in erectile function.A New Strategy for Deleting Animal drugs from Traditional Chinese Medicines based on Modified Yimusake Formula.Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.Physiology of penile erection and pathophysiology of erectile dysfunctionRhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunctionCurrent oral treatments for erectile dysfunction.A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-2272 relax rabbit vaginal wall and clitoral corpus cavernosumThe pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.Inhibition of the tonic contraction in the treatment of erectile dysfunction.Erectile dysfunction - an update of current practice and future strategies.Gene and stem cell therapy for erectile dysfunction.Endothelial dysfunction in diabetic erectile dysfunction.The future of the oral pharmacotherapy of male erectile dysfunction: things to come.Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories.Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction.Nicotine in high concentration causes contraction of isolated strips of rabbit corpus cavernosum.Involvement of Rho kinase and protein kinase C in carbachol-induced calcium sensitization in beta-escin skinned rat and guinea-pig bladdersRegulation of intracellular Ca2+ release in corpus cavernosum smooth muscle: synergism between nitric oxide and cGMP.Metabolic syndrome and urologic diseases.Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens.Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle.Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction.Role of PKCalpha and PKCiota in phenylephrine-induced contraction of rat corpora cavernosa.Rho kinase is involved in Ca2+ entry of rat penile small arteries.Bladder outlet obstruction triggers neural plasticity in sensory pathways and contributes to impaired sensitivity in erectile dysfunction.Topical application of a Rho-kinase inhibitor in rats causes penile erection.Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.The effect of sub-chronic systemic ethanol treatment on corpus cavernosal smooth muscle contraction: the contribution of RhoA/Rho-kinase.Impaired Ca2+ handling in penile arteries from prediabetic Zucker rats: involvement of Rho kinase.
P2860
Q30309468-29179D70-E39C-48F4-B80F-8AB2E44171A0Q33685427-1DFF0B97-B43F-4133-AC20-CC5EE035ACB0Q33755241-AF892346-3A34-4080-8DDA-B1F74A10DCC2Q34312991-C65083FD-6BAF-44BB-9B59-A82EDB7014FBQ34836681-EC5B1A05-8D76-4333-9A59-A9AF8C5E7B04Q35000972-9995E074-B4E7-4169-A687-7F73767A8E1BQ35001011-29FDA0F1-1708-4C12-9A3A-B28B14F084FCQ35044932-BB3140D5-0984-4BD9-AA4D-283728823BA1Q35055194-9B2DC5E2-6001-4B0E-805D-12109D5461F1Q35095163-0F9A3D9F-3914-4DAA-B9C6-95E0718B10A7Q35741898-F6255DBF-7B28-4177-A675-00E2FC9453D8Q36359862-2D74AC49-2D13-4269-8D14-FE6EA2118F53Q36507302-BECB7642-E597-4A1A-AA09-4DE29635680BQ36866594-7F70AF39-E135-482D-A41D-EEFA812E4666Q37825899-1550970C-57A1-43F2-BE99-84DD8E48D933Q38118626-7559EB6C-B152-456F-8B62-948B32363EEBQ40379866-4132BE4F-1D73-4499-B91C-FDF00F9982AAQ41766889-01F94C1C-24EB-4DC2-913A-68714E40AD3FQ42470364-0014ED68-BF1E-4B91-8F63-A86019931B0FQ42757693-43CA1406-013B-4548-BBF9-C130E38A6074Q43263216-A7CD3521-67C7-43BC-B958-D35258FA8B18Q43263503-AD40CFDC-809C-463F-8603-77AA1ACEBF2CQ44306583-238D9AD3-9BD4-4864-9F43-3FB5C0165C3AQ44762859-037055CD-D7CC-4814-8EE9-ED46F67B8B79Q46788956-0FB795A1-4E7D-45B3-887B-BE2BA76F77DBQ50797130-B1636CB4-3EF7-47E0-8ABB-20B8A0601AA2Q51039303-5728F179-9F59-419E-A7F9-A94E3D0EB444Q51373209-F044A6E6-E2FA-4EF4-8780-C8D17B8C7E96Q54224353-7359BE4E-8226-418B-9BF5-BF8C65264695Q54615102-38C67D48-30B2-4D05-8B53-D5CAF0639E75
P2860
Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@ast
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@en
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@nl
type
label
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@ast
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@en
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@nl
prefLabel
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@ast
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@en
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@nl
P2093
P2860
P356
P1476
Y-27632, an inhibitor of Rho-k ...... human penile corpus cavernosum
@en
P2093
P2860
P356
10.1038/SJ.BJP.0704124
P407
P577
2001-06-01T00:00:00Z